SBIR/STTR Research Award
Magnetic Duodeno Ileal Bypass for Metabolic Syndrome in Rhesus Monkeys
Award amount
$829,853Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MAGNAMOSIS INC
- Proposal award date
- 2017-06-01
- Contract end date
- 2019-05-31
- UEI
- YCTCHGENNMU1
- Solicitation number
- PAR14-088
- Topic code
- 300
Research abstract
Project Summary Abstract
Type diabetes mellitus T DM associated with obesity can now be successfully treated by
bariatric surgery The metabolic effect is rapid in part independent of the effect on weight loss
and mediated by gut factors We are exploring the possibility that this beneficial effect on
T DM can be achieved without major surgery by creating a small side to side magnetic
compression anastomosis between the duodenum and the ileum Magnetic Duodenal Ileal
Bypass or DIPASS Our preliminary data in mini pigs suggest that by diverting a small
amount of digestive juices gastric biliary pancreatic to the ileal mucosa this intestinal short
cut is able to mimic the beneficial metabolic and hormonal effect of bypass surgeries on glucose
metabolism This proposal will test the feasibility of inserting the intestinal short cut DIPASS
in a non human primate model of metabolic syndrome the efficacy of the DIPASS procedure
versus sham operation on improving metabolism and the mechanism by which DIPASS
exerts its effect on glucose metabolism We will also collect a unique biobank of tissue samples
that will allow further studies to assess the molecular mechanism by which the procedure exerts
its effect DIPASS can be accomplished minimally invasively as an outpatient procedure using
our previously developed magnetic anastomosis device Magnamosis and newly developed
trans oral delivery devices that enable an incisionless procedure Data generated from this
proposal will have direct translational application and will enable us to develop future studies in
humans Project Narrative
Type diabetes is a major public health problem approaching epidemic proportions in the U S
and globally Growing evidence shows that type diabetes may be successfully treated by
obesity surgery This project aims to demonstrate the feasibility and efficacy of reversing type
diabetes through a novel minimally invasive outpatient surgical procedure utilizing some of the
aspects of obesity surgery However our procedure is not a replacement bariatric surgery but
rather a short procedure that repositions a portion of the small intestine causing a reversal of
certain elements that contribute to type diabetes It is in no way intended to treat obesity
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening